619 related articles for article (PubMed ID: 26548336)
1. Probiotics: a proactive approach to health. A symposium report.
Thomas LV; Suzuki K; Zhao J
Br J Nutr; 2015 Dec; 114 Suppl 1():S1-15. PubMed ID: 26548336
[TBL] [Abstract][Full Text] [Related]
2. The double-edged sword of probiotic supplementation on gut microbiota structure in
Nabavi-Rad A; Sadeghi A; Asadzadeh Aghdaei H; Yadegar A; Smith SM; Zali MR
Gut Microbes; 2022; 14(1):2108655. PubMed ID: 35951774
[TBL] [Abstract][Full Text] [Related]
3. Exploring the influence of the gut microbiota and probiotics on health: a symposium report.
Thomas LV; Ockhuizen T; Suzuki K
Br J Nutr; 2014 Jul; 112 Suppl 1(Suppl 1):S1-18. PubMed ID: 24953670
[TBL] [Abstract][Full Text] [Related]
4. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children.
Guandalini S; Cernat E; Moscoso D
Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345
[TBL] [Abstract][Full Text] [Related]
5. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.
Cunningham-Rundles S; Ahrné S; Johann-Liang R; Abuav R; Dunn-Navarra AM; Grassey C; Bengmark S; Cervia JS
Nutrients; 2011 Dec; 3(12):1042-70. PubMed ID: 22292110
[TBL] [Abstract][Full Text] [Related]
6. [Probiotics in gastroenterology -- from a different angle].
Buzás GM
Orv Hetil; 2013 Feb; 154(8):294-304. PubMed ID: 23419530
[TBL] [Abstract][Full Text] [Related]
7. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.
Ng SC; Lam EF; Lam TT; Chan Y; Law W; Tse PC; Kamm MA; Sung JJ; Chan FK; Wu JC
J Gastroenterol Hepatol; 2013 Oct; 28(10):1624-31. PubMed ID: 23800182
[TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.
Cristofori F; Dargenio VN; Dargenio C; Miniello VL; Barone M; Francavilla R
Front Immunol; 2021; 12():578386. PubMed ID: 33717063
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
10. Clinical evidence for immunomodulatory effects of probiotic bacteria.
Ruemmele FM; Bier D; Marteau P; Rechkemmer G; Bourdet-Sicard R; Walker WA; Goulet O
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):126-41. PubMed ID: 19179874
[TBL] [Abstract][Full Text] [Related]
11. A gastroenterologist's guide to probiotics.
Ciorba MA
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):960-8. PubMed ID: 22504002
[TBL] [Abstract][Full Text] [Related]
12. Treating irritable bowel syndrome with probiotics: the evidence.
Parkes GC; Sanderson JD; Whelan K
Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
[TBL] [Abstract][Full Text] [Related]
13. Probiotics, gut microbiota, and their influence on host health and disease.
Sánchez B; Delgado S; Blanco-Míguez A; Lourenço A; Gueimonde M; Margolles A
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27500859
[TBL] [Abstract][Full Text] [Related]
14. Intestinal microbiota, diet and health.
Power SE; O'Toole PW; Stanton C; Ross RP; Fitzgerald GF
Br J Nutr; 2014 Feb; 111(3):387-402. PubMed ID: 23931069
[TBL] [Abstract][Full Text] [Related]
15. A Review on Gut Remediation of Selected Environmental Contaminants: Possible Roles of Probiotics and Gut Microbiota.
Feng P; Ye Z; Kakade A; Virk AK; Li X; Liu P
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30577661
[TBL] [Abstract][Full Text] [Related]
16. New insights into the impact of the intestinal microbiota on health and disease: a symposium report.
Thomas LV; Ockhuizen T
Br J Nutr; 2012 Jan; 107 Suppl 1():S1-13. PubMed ID: 22260731
[TBL] [Abstract][Full Text] [Related]
17. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
18. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.
Geirnaert A; Calatayud M; Grootaert C; Laukens D; Devriese S; Smagghe G; De Vos M; Boon N; Van de Wiele T
Sci Rep; 2017 Sep; 7(1):11450. PubMed ID: 28904372
[TBL] [Abstract][Full Text] [Related]
19. Probiotics in gastrointestinal disorders.
Quigley EM
Hosp Pract (1995); 2010 Nov; 38(4):122-9. PubMed ID: 21068536
[TBL] [Abstract][Full Text] [Related]
20. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
Celiberto LS; Bedani R; Rossi EA; Cavallini DC
Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
